Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • Ovarian Cancer
Type
Interventional
Phase
Not Applicable
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention

Participation Requirements

Age
Between 25 years and 45 years
Gender
Only males

Description

Eligible women will choose for the innovative or standard risk-reducing option themselves.

Eligible women will choose for the innovative or standard risk-reducing option themselves.

Tracking Information

NCT #
NCT02321228
Collaborators
Not Provided
Investigators
Principal Investigator: Joanne A de Hullu, MD, PhD University Medical Center Nijmegen Principal Investigator: Rosella PM Hermens, PhD Scientific Institute for Quality of Healtcare, UMCNijmegen Principal Investigator: Nicoline Hoogerbrugge, MD, PhD University Medical Center Nijmegen